Leaving BNY Website

 

You are leaving the BNY Mellon's Depositary Receipts' Website.
Linked sites are not under the control of The Bank of New York Mellon Corporation or any of its subsidiaries or affiliates (together, the "Company") and the Company is not responsible for the content of any linked site or any link contained in a linked site. If you choose to link to a website not controlled by the Company, you do so entirely at your own risk and the Company makes no warranties, either express or implied, concerning the content of such site, including the accuracy, completeness, reliability or suitability thereof for any particular purpose, nor does the Company warrant that such site or content is free from any claims of copyright, trademark or other infringement of the rights of third parties or that such site or content is devoid of viruses or other contamination. The Company does not guarantee the authenticity of documents on the Internet. Links to other sites do not imply any endorsement of or responsibility for the opinions, ideas, products, information or services offered at such sites, or any representation regarding the content at such sites. The Company reserves the right to terminate any link at any time.

Do you wish to continue to the linked site on these terms?

Stay On Page
Leave Page

© 2025 The Bank of New York Mellon Corporation

Depositary Receipt business and services are conducted through The Bank of New York Mellon.

BNY - DR Legal Disclaimer
  

To learn more about DRs, please contact DRBrokerSolutions@bny.com.

 

The information and data provided herein are provided for general informational purposes only.  BNY does not warrant or guarantee the accuracy, timeliness or completeness of any such information or data.  BNY does not undertake any obligation to update or amend any information or data, and may change, update or amend any information or data at any time without prior notice.

 

BNY provides no advice, recommendation or endorsement with respect to any company or securities.  No information or data is intended to provide legal, tax, accounting, investment, financial, trading or other advice on any matter, and is not to be used as such.  We expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon any information or data, including market value loss on the sale or purchase of securities or other instruments or obligations.

 

Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.

 

BNY collects fees from DR holders pursuant to the terms and conditions of the DRs and any deposit agreement under which they are issued.  From time to time, BNY may make payments to an issuer to reimburse and/or share revenue from the fees collected from DR holders, or waive fees and expenses to an issuer for services provided, generally related to costs and expenses arising out of establishment and maintenance of the DR program.  BNY may pay a rebate to brokers in connection with unsponsored DR issuances; brokers may or may not disclose or pass back some or all of such rebate to the DR investor.  BNY may also use brokers, dealers or other service providers that are affiliates and that may earn or share fees and commissions.

 

BNY may execute DR foreign currency transactions itself or through its affiliates, or the Custodian or the underlying Company may execute foreign currency transactions and pay US dollars to BNY.  In those instances where it executes DR foreign currency transactions itself or through its affiliates, BNY acts as principal counterparty and not as agent, advisor, broker or fiduciary.  In such cases, BNY  has no obligation to obtain the most favorable exchange rate, makes no representation that the rate is a favorable rate and will not be liable for any direct or indirect losses associated with the rate. BNY earns and retains revenue on its executed foreign currency transactions based on, among other things, the difference between the rate it assigns to the transaction and the rate that it pays and receives for purchases and sales of currencies when buying or selling foreign currency for its own account.  The methodology used by BNY to determine DR conversion rates is available to registered Owners upon request or can be accessed here.  In those instances where BNY's Custodian executes DR foreign currency transactions, the Custodian has no obligation to obtain the most favorable exchange rate or that the method by which the rate will be determined will be the most favorable rate, and BNY makes no representation that the rate is a favorable rate and will not be liable for any direct or indirect losses associated with the rate.  In certain instances, BNY may receive dividends and other distributions from an issuer of securities underlying DRs in U.S. dollars rather than in a foreign currency.  In such cases, BNY will not engage in or be responsible for any foreign currency transactions and it makes no representation that the rate obtained by an issuer is a favorable rate and it will not be liable for any direct or indirect losses associated with the rate.

 

BNY is a global investments company dedicated to helping its clients manage and service their financial assets throughout the investment lifecycle.  BNY is the corporate brand of The Bank of New York Mellon Corporation (NYSE: BK).

 

BNY's name, brand and/or trademarks may not be used, copied or reproduced without the prior express written consent of BNY.

 

DEPOSITARY RECEIPTS ARE NOT INSURED BY THE FDIC OR ANY OTHER GOVERNMENT AGENCY, ARE NOT DEPOSITS OR OTHER OBLIGATIONS OF, AND ARE NOT GUARANTEED BY, BNY AND ARE SUBJECT TO INVESTMENT RISKS INCLUDING POSSIBLE LOSS OF PRINCIPAL AMOUNT INVESTED.

 

Please also see "Terms of Use."

ACCEPT

Please enable cookies in your browser if you wish to proceed.

Regulation S Disclaimer

 

Access To This Company Profile Is Restricted To Non-U.S. Persons Outside The United States Within The Meaning Of Regulation S Under The U.S. Securities Act Of 1933, As Amended (The "Securities Act").1

 

This company profile does not constitute an offer to sell or the solicitation of an offer to buy any securities in any jurisdiction or under any circumstances in which such offer or solicitation is unlawful.

 

Each person accessing this company profile, by so doing, will be deemed to have acknowledged that: (1) It is not a U.S. person (within the meaning of Regulation S under the Securities Act) and is located outside the U.S. (within the meaning of Regulation S under the Securities Act); and (2) Any securities described herein (A) have not been and will not be registered under the Securities Act or with any securities regulatory authority of any state or other jurisdiction and (B) may not be offered, sold, pledged or otherwise transferred except to persons outside the U.S. in accordance with Regulation S under the Securities Act pursuant to the terms of such securities.

 

If you agree with and accept the foregoing and the Terms of use governing this site, please select "Accept" below. Otherwise, press "Decline" to return to the previous page.

 

1 As defined in the Securities Act, the term "U.S Person" means: (1) any natural person resident in the United States; (2) any partnership or corporation organized or incorporated under the laws of the United States; (3) any estate of which any executor or administrator is a U.S. person; (4) any trust of which any trustee is a U.S. person; (5) any agency or branch of a foreign entity located in the United States; (6) any non-discretionary account or similar account (other than an estate or trust) held by a dealer or other fiduciary for the benefit or account of a U.S. person; (7) any discretionary account or similar account (other than an estate or trust) held by a dealer or other fiduciary organized, incorporated, or (if an individual) resident in the United States; and (8) any partnership or corporation if: (A) organized or incorporated under the laws of any foreign jurisdiction; and (B) formed by a U.S. person principally for the purpose of investing in securities not registered under the Securities Act, unless it is organized or incorporated, and owned, by accredited investors (as defined in Rule 501(a)) who are not natural persons, estates or trusts.

I Accept Decline

© 2024 The Bank of New York Mellon Corporation
Depositary Receipt business and services are conducted through The Bank of New York Mellon.

Back to Daily DR Market Summary

StreetAccount Summary - Asian Market Preview: Nikkei Futures (0.22%), Hang Seng Futures +0.60%, ASX SPI 200 (0.45%), S&P Futures +0.07% (07:40 HKT)

Sep 17 ,2025

  • Synopsis:

    • Asia equities poised for a mostly lower open Wednesday. Futures in Japan, Australia and South Korea were softer, while Hong Kong strengthened. Japan ADRs were mixed, while Golden Dragon China index rose sharply. US contracts steady following moderate overnight losses that saw S&P and Nasdaq fading slightly off Monday's record highs; Nasdaq 100 index was down after nine straight days of gains. Mild gain in SOX index offered a positive tech signal, though US Big Tech finished mostly lower with Nvidia (NVDA) among the laggards. US Treasuries were mostly firmer with yields down ~2-3bp at the short end; 20Y auction was well received. Dollar index was down 0.6%, its worst daily performance since 22-Aug. Gold finished up 0.2%. Bitcoin futures were up 1.3%. WTI crude settled up 1.9%.

    • Generally benign session overnight though volumes somewhat higher than the recent average. Focus now squarely on the upcoming FOMC decision. Some thoughts that announcement effects skewed to the downside given a 25bp rate cut is fully priced in. Fed commentary and dot plot stand to affect market expectations for ~150 bp in total easing over the next year. Other events were viewed as secondary -- appeals court blocked Trump from firing Fed Governor Cook as she challenges her dismissal, while Senate confirmed Miran to the board. Better-than-expected data (retail sales, import prices) also had limited impact though upside surprises generally seen as a hinderance to Fed easing.

    • In Asia, BOJ meeting begins tomorrow though a rate hike all but ruled out amid ongoing debate about whether they can move in the opposite direction as the Fed with next meetings to be held so close to each other. BOJ also presages campaigning for the 22-Sep LDP presidential election. October and December viewed as next viable windows of opportunity to hike, albeit each only about a third priced in. Elsewhere, markets continue to monitor thawing US-India trade tensions. Latest Trump rhetoric was positive after the latest call with India PM Modi. Dialogue seemingly still on track after talks resumed this week. Yet, resolution over the Russian oil dispute remain unclear. Macro calendar brings Japan customs trade data; exports seen falling for a fourth straight month in nominal terms, though price factor masking consistent growth in real terms.

  • Pre-open Company News:

    • StreetAccount Macro Headlines:

    • 2229.JP -- Oasis Management disclosing 5.98% stake in CALBEE

    • 600803.CH -- ENN Natural Gas declares H1 dividend CNY0.18/share

    • 1088.HK -- China Shenhua Energy reports August coal production 28.6Mt vs year-ago 28.7Mt

    • 500570.IN -- Jaguar Land Rover extends hack-related production halt to 24-Sep (roughly 13:00 IT)

    • Hong Kong stock connect daily turnover

    • 600276.CH -- NMPA approves Jiangsu Hengrui Pharmaceuticals SHR-1826, Adebrelimab, and Bevacizumab to phase IB/II trial for treatment of solid tumors

    • 688036.CH -- Shenzhen Transsion Holding downgraded to neutral from buy at Goldman Sachs

    • TNG.VN -- TNG Investment & Trading declares dividend VND500/share

    • 2866.HK -- COSCO SHIPPING Development general manager Zhang Mingwen resigns, effective today

    • 2097.HK -- MIXUE Group initiated buy at Changjiang Securities (timing uncertain)

    • 826.HK -- Tiangong International initiated overweight at Industrial Securities (timing uncertain)

    • 532313.IN -- Mahindra Lifespace Developers discloses redevelopment project in Mumbai with potential GDV INR17.00B

    • 2252.HK -- Shanghai MicroPort MedBot (Group) downgraded to overweight from buy at Northeast Securities (timing uncertain)

  • On Deck:

    • China:

      • Economic:

        • 08:00 CST: Foreign Direct Investment Y/Y; consensus

    • Japan:

      • Economic:

        • 08:50 JST: Import NSA Y/Y (Preliminary); consensus (3.8%)

        • 08:50 JST: Trade Balance NSA (Preliminary); consensus

        • 08:50 JST: Export NSA Y/Y (Preliminary); consensus (1.05%)

    • Australia:

      • Earnings:

        • Ioneer (INR.AU)

    • New Zealand:

      • Economic:

        • 10:45 NZST: Current Account; consensus

  • Market Data:

    • Gold (Dec 25): +$7.00 or +0.19% to $3732.10

    • WTI Crude (Oct 25): +$0.09 or +0.14% to $64.61

    • $-¥: (1.10) or (0.75%) to 146.3160

    • $-KRW: (7.52) or (0.54%) to 1377.6400

    • A$-$: +0.00 or +0.21% to 0.6684

    • $-INR: (0.24) or (0.27%) to 87.8847

    • $-CNY: (0.01) or (0.08%) to 7.1134

This information and data is provided for general informational purposes only. The Bank of New York Mellon and our information suppliers do not warrant or guarantee the accuracy, timeliness or completeness of this information or data. We provide no advice nor recommendation or endorsement with respect to any company or securities. We do not undertake any obligation to update or amend this information or data. Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.
Please refer to "Terms Of Use".

DEPOSITARY RECEIPTS:
NOT FDIC, STATE OR FEDERAL AGENCY INSURED
MAY LOSE VALUE
NO BANK, STATE OR FEDERAL AGENCY GUARANTEE